A Prostatic stent [http://www.touchbriefings.com/pdf/33/gs031_p_16dijk.pdf] is used to keep open the male
urethraand allow the passing of urine in cases of prostatic obstructionand Lower urinary tract symptoms(LUTS). Prostatic obstruction [Guidelines on Benign Prostatic Hyperplasia. European Association of Urology.http://www.uroweb.org/fileadmin/user_upload/Guidelines/BPH.pdf | page 36 | 12 September 2006] is a common condition with a variety of etiologies. Benign prostatic hyperplasia(BPH) is the most common cause [ [http://hcd2.bupa.co.uk/fact_sheets/html/bph.html Enlarged prostate gland - treatment, symptoms and cause ] ] , but obstruction may also occur acutely after treatment for BPH such as Transurethral needle ablation of the prostate(TUNA), Transurethral resection of the prostate(TURP), Transurethral microwave thermotherapy(TUMT), Prostate canceror after radiation therapy.
There are two types of prostatic stent: temporary and permanent.
Although a permanent prostatic stent is not a medical treatment, it falls under the classification of a surgical procedure [ [http://www.urologychannel.com/prostate/bph/treatment_med.shtml Benign Prostatic Hyperplasia (BPH)/Enlarged prostate - Medical Treatment - urologychannel ] ] . Placement of a permanent prostatic stent is carried out as an outpatient treatment under local, topical or spinal anesthesia and usually takes about 15-30 minutes. A temporary prostatic stent can be inserted in a similar manner to a Foley catheter, requiring only topical anesthesia.
Food and drug administration (FDA) approved stents
At the present time, there is one temporary prostatic stent that has received
FDAapproval [http://www.fda.gov/cdrh/pdf6/p060010b.pdf] . The Spanner [http://www.thespanner.com] temporary prostatic stent maintains urine flow and allows natural voluntary urination. The prostatic stentis a completely internal device and can be inserted and removed as easily as a Foley catheter[The Journal of Urology vol. 177, , March 2007, Neal D Shore et al] . It permits normal bladder and sphincter functioning and can be worn comfortably by patients [Corica AP, Larson BT, Sagaz AG et al. A novel temporary prostatic stent for the relief of prostatic urethral obstruction. BJU Int 2004;93:346-48] . The temporary prostatic stent is typically used to help patients maintain urine flow after procedures that cause prostatic swelling, such as bracytherapy, cryotherapy, TUMT, TURP. It has also become an effective differential diagnostic tool for identifying poor bladder function separate from prostatic obstruction.
Permanent stents are often metal coils [ [http://www.urotoday.com/browse_categories/bph__male_luts/european_urology__the_bellshaped_nitinol_prostatic_stent_in_the_treatment_of_lower_urinary_tract_symptoms_experience_in_108_patients.html UroToday - European Urology - The Bell-Shaped Nitinol Prostatic Stent in the Treatment of Lower Urinary Tract Symptoms: Experience in 108 Patients ] ] , which are inserted into the male Urethra. The braided mesh is designed to expand radially, applying constant gentle pressure to hold open the sections of the urethra that obstruct the flow or urine. The open, diamond-shape cell design of the stent allows the stent to eventually become embedded in the urethra, thus minimizing the risk for encrustation and migration. Permanent stents are used to relieve urinary obstructions secondary to
benign prostatic hyperplasia(BPH), recurrent bulbar Urethral stricture(RBUS), or detrusor external sphincter dyssynergia (DESD) [ [http://www.bcca.org/ief/desd.htm DESD Resource Page ] ] . The main motive for removal of permanent stents is worsening of symptoms even with device fitted. Other reasons have been migration, clot retention, haematuria, and urinary retention. The only FDA approved permanent stent is the Urolume. Usually, permanent stents are used only for men who are unwilling or unable to take medications or who are reluctant or unable to have surgery. Most doctors don't consider permanent stents a viable long-term treatment for most men. [ [http://www.mayoclinic.com/health/enlarged-prostate-bph/BP99999/PAGE=BP00015 Enlarged prostate (BPH) guide - MayoClinic.com ] ]
Advantages and disadvantages to permanent prostatic stents
* They can be placed in less than 15 minutes under regional anesthesia.
* Bleeding during and after surgery is minimal.
* The patient can be discharged the same day.
* They may cause increased urination and limited incontinence.
* They may cause mild discomfort
* They can become dislodged, leading to urinary obstruction or total incontinence.
* They can become infected and can be very difficult to remove.
* Their fixed diameter limits subsequent endoscopic surgical options.
Advantages and disadvantages to temporary prostatic stents
* They can be placed in less than 15 minutes in a manner similar to Foley catheter placement.
* They can be easily removed, also in a manner similar to Foley catheter removal.
* They allow the patient to retain volitional voiding.
* Patients prefer a temporary stent to Foley catheter use.
* A temporary stent will not provide voiding function if the patient does not have a working bladder and external sphincter.
* The stent may cause mild discomfort.
* They may cause urinary frequency which usually subsides after the first 78 hours.
* If the stent is not sized correctly or placed correctly, the patient may experience urinary retention or slight incontinence until the problem is corrected.
Benign prostatic hyperplasia
Lower urinary tract symptoms
title = The Spanner website
publisher = AbbeyMoor Medical INC
url = http://www.thespanner.com
accessdate = 2008-08-29
Wikimedia Foundation. 2010.
Look at other dictionaries:
Stent — For people named Stent, see Stent (surname). Stent Intervention MeSH D015607 In the technical vocabulary of medicine, a stent is an artificial tube inserted into a natural passage/conduit in the … Wikipedia
Benign prostatic hyperplasia — (BPH) also known as nodular hyperplasia, benign prostatic hypertrophy (technically a misnomer) or benign enlargement of the prostate (BEP) refers to the increase in size of the prostate in middle aged and elderly men. To be accurate, the process… … Wikipedia
Transurethral microwave thermotherapy — (TUMT) is one of a number of effective and safe [Stravodimos KG, Goldfischer ER, Klima WJ, Jabbour ME, Smith AD. 1998 Jun. Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: a single institution experience. |… … Wikipedia
Prostate — For the female prostate gland, see Skene s gland. For the prostrate body position, see Prostration. Prostate Male Anatomy … Wikipedia
Lower urinary tract symptoms — (LUTS) are a common problem affecting approximately 40% of older men [RoehrbornCG and McConnell JD: Etiology, pathophusiology, epidemiology, and natural history of benign prostatic hyperplasia. Campell s Urology. WB Saunders Co 2002; chapt 38,… … Wikipedia
Urinary retention — with greatly enlarged bladder at CT. ICD 10 R33 ICD 9 … Wikipedia
Urinary catheterization — Intervention ICD 9 CM 57.94, MeSH … Wikipedia
Memokath — n. trade name for a prostatic stent used as a minimally invasive treatment for men with lower urinary tract symptoms due to benign prostatic hyperplasia (see prostate gland) who are unfit for surgery. The stent is placed in the prostatic section… … The new mediacal dictionary
Transurethral resection of the prostate — Interventions infobox Name = Transurethral resection of the prostate Caption = ICD10 = ICD9 = 60.29 MeshID = D OtherCodes = Transurethral resection of the prostate (also known as TURP, plural TURPs and as a transurethral prostatic resection TUPR) … Wikipedia
Urinary tract infection — DiseaseDisorder infobox Name = Urinary tract infection ICD10 = ICD10|N|39|0|n|30 ICD9 = ICD9|599.0 ICDO = Caption = Multiple rod shaped bacteria shown between white cells at urinary microscopy from a patient with urinary tract infection. OMIM =… … Wikipedia